Open in App
  • Local
  • Headlines
  • Election
  • Crime Map
  • Sports
  • Lifestyle
  • Education
  • Real Estate
  • Newsletter
  • The Advocate-Messenger

    July is Sarcoma Awareness Month

    By Special to The Advocate-Messenger,

    2024-07-16
    https://img.particlenews.com/image.php?url=3bBIdK_0uTHRoFa00

    Sarcoma Foundation of America

    Chances are you’ve heard of breast, lung, or skin cancer. For the more than 17,000 Americans who develop sarcoma every year, the first time they hear of this rare cancer will be when they are diagnosed. This understudied, underfunded cancer can develop anywhere in the body. While just one percent of adult cancers are sarcoma, sarcomas make up one in six childhood cancers.

    For July, which is Sarcoma Awareness Month, the Sarcoma Foundation of America invites you to join us in raising awareness of the disease.

    On Saturday, July 26, Louisville’s Churchill Downs will join landmarks and buildings across the country to light their exteriors yellow to promote sarcoma awareness.

    The Louisville Race to Cure Sarcoma, held Saturday, August 10, will bring together local sarcoma patients, survivors, and caregivers to support research for better treatments and an end to sarcoma.

    About Sarcoma Foundation of America

    Sarcoma Foundation of America (SFA), a 501(c)(3) nonprofit charitable organization, is an advocate for increased research to find new and better therapies with which to treat patients with sarcoma. The organization raises money to privately fund grants for sarcoma researchers and conducts education and advocacy efforts on behalf of sarcoma patients. For more information, please visit www.curesarcoma.org .

    The post July is Sarcoma Awareness Month appeared first on The Advocate-Messenger .

    Related Search

    Sarcoma awarenessSarcoma researchSarcoma foundation of AmericaChurchill downsCancer ResearchCancer

    Comments /

    Add a Comment

    YOU MAY ALSO LIKE

    Local News newsLocal News
    Jacksonville Today5 hours ago

    Comments / 0